Product Information

HOME > Product Information > New Sekikodechin

Pharmaceutical products

New Sekikodechin

Risk Classification:

New Sekikodechin

Coughing is a symptom of throat and bronchial disease.
Cough which continues for a long period of time will not only infect the throat and make the voice hoarse, but will stimulate the lungs more than required, increase the blood pressure, reduce physical strength and weaken resistance to diseases.
New Sekikodechin is a drug that provides relief from cough, and is also effective for cough that accompanies phlegm.


Composition and Quantity [Ingredients / Contents]
Daily dose (3 capsules)
(1 capsule: 280mg)
dl-methyl ephedrine hydrochloride: 75mg
Chlorpheniramine Maleate: 9mg
Potassium Guaiacolsulfonate: 270mg
Anhydrous caffeine: 120mg
Additives: Crystalline cellulose, Anhydrous calcium hydrogen phosphate, Talc, Light anhydrous silicic acid, Magnesium stearate, Hydroxypropyl starch, Gelatin, Titanium oxide, Sodium lauryl sulfate and Macrogol
Efficacy and Effectiveness [Indication]
Cough, phlegm and asthma
Dosage and Administration
15 years or older: 1 capsule at one time
Take thrice a day within 30 minutes after eating with water or hot water.
Must not be given to children below 15 years old.
Packaging and price (excluding tax)
6 capsules (for 2 days), 500 yen

Product inquiry

Product inquiry

Please feel free to contact us using the inquiry form for more information on the products.

<< Return to previous page


▲To top of page

Copyright (c) Shiseido Pharmaceutical Co., Ltd. All Rights Reserved.